Julian J K Lohmeyer

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Dna Methylation

Top Venues

ACS central science

bioRxiv : the preprint server for biology

Science immunology

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Idit Sagiv-Barfi, Debra K Czerwinski, Tanaya Shree, Julian J K Lohmeyer, Ronald Levy
Intratumoral immunotherapy relies on B and T cell collaboration. Science immunology 7 (71) (2022)
Tanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, Debra K Czerwinski, Joseph G Schroers-Martin, Gladys M Rodriguez, Sara Beygi, Alyssa M Kanegai, Karen S Corbelli, Etelka Gabriel, David M Kurtz, Michael S Khodadoust, Neel K Gupta, Lauren S Maeda, Ranjana H Advani, Ash A Alizadeh, Ronald Levy
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity. Blood cancer discovery 3 (2) (2022)
Ole A W Haabeth, Julian J K Lohmeyer, Adrienne Sallets, Timothy R Blake, Idit Sagiv-Barfi, Debra K Czerwinski, Blaine McCarthy, Abigail E Powell, Paul A Wender, Robert M Waymouth, Ronald Levy
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory. ACS central science 7 (7) (2021)
Ole A W Haabeth, Julian J K Lohmeyer, Adrienne Sallets, Timothy R Blake, Idit Sagiv-Barfi, Debra K Czerwinski, Blaine McCarthy, Abigail E Powell, Paul A Wender, Robert M Waymouth, Ronald Levy
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory. bioRxiv : the preprint server for biology (2021)